Section Arrow
BAX.NYSE
- Baxter International
Quotes are at least 15-min delayed:2026/04/03 17:16 EDT
Regular Hours
Last
 16.68
-0.1 (-0.60%)
Day High 
17.04 
Prev. Close
16.78 
1-M High
19.97 
Volume 
6.51M 
Bid
16.61
Ask
16.85
Day Low
16.31 
Open
16.49 
1-M Low
15.73 
Market Cap 
8.63B 
Currency 美元 
P/E -- 
%Yield 2.16 
10-SMA 16.53 
20-SMA 17.11 
50-SMA 19.12 
52-W High 32.68 
52-W Low 15.73 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.87/2.13
Enterprise Value
18.33B
Balance Sheet
Book Value Per Share
11.87
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
12.78B
Operating Revenue Per Share
29.70
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc44.28+0.28+0.64%30.21PE
BAXBaxter International16.68-0.1-0.60%-- 
AVTRAvantor7.9+0.13+1.67%-- 
HOLXHologic75.65+0.05+0.07%31.37PE
XRAYDENTSPLY SIRONA11.63-0.03-0.26%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.